What is the appropriate ceftriaxone dose for treating leptospirosis in a 54‑kg adolescent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Dosing for Leptospirosis in a 54 kg Adolescent

For a 54 kg adolescent with leptospirosis, administer ceftriaxone 1 gram IV once daily for 7 days.

Dosing Rationale

The standard pediatric dose of ceftriaxone for severe bacterial infections is 50-100 mg/kg/day 1, 2, 3. For this 54 kg adolescent:

  • 50 mg/kg/day = 2,700 mg (2.7 grams)
  • 100 mg/kg/day = 5,400 mg (5.4 grams)

However, the maximum adult dose of 2 grams daily should not be exceeded 4. Since this adolescent's weight-based calculation would exceed adult dosing, use the standard adult dose.

Evidence-Based Recommendation

Multiple clinical trials in leptospirosis have established 1-2 grams IV daily as the effective dose 5, 6:

  • A randomized trial of 173 patients with severe leptospirosis demonstrated that ceftriaxone 1 gram IV daily for 7 days was equally effective as penicillin G, with median fever resolution of 3 days in both groups 5
  • A study of 22 patients with severe late leptospirosis using ceftriaxone 2 grams IV daily showed 21/22 patients recovered successfully 6
  • Short-course therapy (3-6 days) with ceftriaxone 1-2 grams daily achieved apyrexia within 2 days with no relapses 7

Treatment Duration

Standard duration is 7 days 5, 6. However, if the patient responds rapidly with defervescence within 48 hours, shorter courses of 3-6 days may be sufficient 7, 8. This should be individualized based on clinical response—continue until the patient has been afebrile for at least 24-48 hours and shows clinical improvement.

Key Advantages of Ceftriaxone

  • Once-daily dosing improves compliance and reduces nursing burden 5
  • Broader spectrum than penicillin, covering potential co-infections 5
  • Excellent tissue penetration with prolonged half-life (5.8-8.7 hours in adults, 4.3-4.6 hours in children) 4
  • Proven efficacy in severe leptospirosis with jaundice, renal failure, and hemorrhagic complications 9, 10

Practical Administration

Administer as IV infusion over 30 minutes 4. The drug can be given once daily at any consistent time. Monitor for Jarisch-Herxheimer reaction (fever, chills, hypotension) within the first 24 hours of treatment, which occurs in some patients with leptospirosis 8.

Common Pitfall to Avoid

Do not use weight-based dosing that exceeds adult maximum doses in adolescents approaching adult size. The FDA label clearly states pediatric dosing should not exceed normal adult doses 3. For this 54 kg patient, 1 gram daily is appropriate rather than calculating 50-100 mg/kg which would yield excessive doses.

References

Research

Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Research

Use of ceftriaxone in patients with severe leptospirosis.

International journal of antimicrobial agents, 2006

Research

Short-course treatment with ceftriaxone for leptospirosis: a retrospective study in a single center in Eastern France.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.